Another treatment option for those affected by Alzheimer's disease
Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.
Science Daily23h
Opening for a new type of drug for Alzheimer's disease
A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...
Natural killer cells offer hope for hard-to-treat pediatric sarcomas
University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...
Around 10 million people in the UK today suffer it
Health charity Scleroderma & Raynaud's UK (SRUK) is urging the public to take a 60-second online test to find out if they may ...
Relmada acquires new Tourette syndrome treatment asset
CORAL GABLES, Fla. - Relmada Therapeutics , Inc. (NASDAQ:RLMD), a clinical-stage biotechnology firm with a market capitalization of $11.5 million, has announced the acquisition of Sepranolone, a Phase ...
How to Exercise Outside With Raynaud’s Syndrome Without Freezing Your Fingers Off
Even if you’ve kept the blood flowing throughout your run or other activity, you may be prone to a Raynaud’s attack ...